Salvage liver transplantation in the treatment of hepatocellular carcinoma： A Meta-analysis

• Published in: World journal of gastroenterology : WJG Vol. 18; no. 19; pp. 2415 - 2422
• Main Authors: Li, Hong-Yu, Wei, Yong-Gang, Yan, Lv-Nan, Li, Bo
• Format: Journal Article
• Language: English
• Published: United States Baishideng Publishing Group Co., Limited 21.05.2012
• Subjects: Brief; Carcinoma, Hepatocellular - mortality; Carcinoma, Hepatocellular - surgery; Disease-Free Survival; Humans; Liver Neoplasms - mortality; Liver Neoplasms - surgery; Liver Transplantation; Meta分析; Neoplasm Recurrence, Local; Salvage Therapy; Survival Rate; 抢救; 时间标准; 生存率; 移植治疗; 肝癌; 肝移植; 随机效应模型; Primary liver transplantation; Hepatocellular carcinoma; Salvage liver transplantation; Survival rate; Meta-analysis
• ISSN: 1007-9327; 2219-2840
• DOI: 10.3748/wjg.v18.i19.2415

AIM： To evaluate survival and recurrence after salvage liver transplantation （SLT） for the treatment of hepatocellular carcinoma （HCC） compared with primary liver transplantation （PLT） using a meta-analysis. METHODS： Literature on SLT versus PLT for the treatment of HCC published between 1966 and July 2011 was retrieved. A metaanalysis was conducted to esti- mate pooled survival and disease-free rates. A fixed or random-effect model was established to collect the data. RESULTS： The differences in overall survival and disease-free survival rates at 1-year, 3-year and 5-year survival rates were not statistically significant between SLT group and PLT group （P 〉 0.05）. After stratifying the various studies by donor source and Milan criteria, we found that： （1） Living donor liver transplantation recipients had significantly higher 1-year survival rate, lower 3-year and 5-year survival rates compared with deceased-donor liver transplantation （DDLT） recipients. And in DDLT recipients they had better 1-year and 5-year disease-free survival rate in SLT group; and （2） No difference was seen in 1-year, 3-year and 5-yearsurvival rates between two groups who beyond Milan criteria at the time of liver transplantation. CONCLUSION： SLT can be effectively performed for patients with recurrence or deterioration of liver function after hepatectomy for HCC. It does not increase the perioperative mortality and has a similar long-term survival rates compared to PLT.